Cargando…
Comparison Between Intravesical Chemotherapy Epirubicin and Mitomycin-C after TURB vs TURB Alone With Recurrence Rate of Non-Muscle Invasive Bladder Cancer: Meta-Analysis
BACKGROUND: Bladder cancer is still a burden on the world of oncology medicine, which every year affects about 3.4 million people globally with 430,000 new cases per year. It is the fourth most common cancer in men and eighth most common women malignancy in the world. This makes bladder cancer a “si...
Autores principales: | Daryanto, Besut, Purnomo, Athaya Febriantyo, Seputra, Kurnia Penta, Budaya, Taufiq Nur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences of Bosnia and Herzegovina
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478828/ https://www.ncbi.nlm.nih.gov/pubmed/36200115 http://dx.doi.org/10.5455/medarh.2022.76.198-201 |
Ejemplares similares
-
Methylenetetrahydrofolate Reductase C677T (rs1801133) Polymorphism Is Associated with Bladder Cancer in Asian Population: Epigenetic Meta-Analysis as Precision Medicine Approach
por: Purnomo, Athaya Febriantyo, et al.
Publicado: (2023) -
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
por: Breyer, Johannes, et al.
Publicado: (2023) -
Nada te turbe /
por: Pérez Alonso, Susana, 1958-
Publicado: (2003) -
The HELENA study: Hexvix(®)-TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy—a prospective randomized controlled open-label multicenter non-inferiority study
por: Gierth, M., et al.
Publicado: (2021) -
Monosymptomatic Nocturnal Enuresis Treatment Using Alarm-Therapy and Desmopressin: A Meta-analysis Approach
por: Purnomo, Athaya Febriantyo, et al.
Publicado: (2021)